icon-folder.gif   Conference Reports for NATAP  
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
Long-Term Follow-up of Patients with Chronic HCV Infection and Compensated or Decompensated Cirrhosis Following Treatment with Sofosbuvir-Based Regimens
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Alessandra Mangia1, Eric Lawitz2, Edward Gane3, Brian Conway4, Peter J. Ruane5, Armando Abergel6, Brian McNabb7, Anu Osinusi7, Frances Chen7, Hadas Dvory-Sobol7, Diana M. Brainard7, G. Mani Subramanian7, Barbara Leggett8, Jose Luis Calleja9, Kosh Agarwal10, Ziad Younes11, Andrew Muir12
1Casa Sollievo della Sofferenza Hospital, San Giovanni Rotondo, Italy; 2Texas Liver Institute, University of Texas Health San Antonio, TX, USA; 3New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand; 4Vancouver Infectious Diseases Centre, Vancouver, BC, Canada; 5Ruane Medical & Liver Health Institute, Los Angeles, CA, USA; 6Centre Hospitalier Universitaire Estaing Clermont-Ferrand, France; 7Gilead Sciences Inc., Foster City, CA, USA; 8School of Medicine, University of Queensland, Brisbane, Australia;
9Hospital Universitario Puerta de Hierro, Madrid, Spain; 10Kings College Hospital NHS Trust Foundation, London, UK; 11GastroOne, Germantown, TN, USA; 12Duke University School of Medicine, Durham, NC, USA